Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $391 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating on Humana (NYSE:HUM) and maintained a $391 price target.

April 10, 2024 | 2:18 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating on Humana and maintained a $391 price target.
The reiteration of a Neutral rating and maintenance of the price target by a prominent analyst suggests no significant short-term price movement is expected. The analyst's view likely reflects a balanced outlook on the company's current valuation and future prospects.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100